arrow
返回期刊详情
Blood Cancer Journal 封面图

Blood Cancer Journal

IF11.6
论文数2231
被引数8358
期刊论文 2231
发表时间
Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study多发性骨髓瘤伴严重肾功能损害患者中的地诺单抗:一项多中心二期研究
delete2026-11-02
delete0
deleteOAAI
deleteElizabeth K. O’Donnell; Omar Nadeem; Jacob P. Laubach; Giada Bianchi; Andrew R. Branagan; Brea C. Lipe; Paul G. Richardson; Ehsan Malek; Robb S. Friedman; Ajay K. Nooka; Robert Redd; Noopur S. Raje; Andrew J. Yee
delete分享
delete收藏
Biomarkers of cellular senescence and their association with frailty, clinical outcomes, and survival in multiple myeloma细胞衰老的生物标志物及其与多发性骨髓瘤中虚弱、临床结局和生存期的关联
delete2026-10-30
delete0
deleteOAAI
deleteNadine Abdallah; Byron Smith; Thomas A. White; Amanda Heeren; Tanya M. Wildes; Rosalynn Marar; Claire Yee; Anna Bodily; Brian Kotajarvi; Sarah Aug; Francis Buadi; Prashant Kapoor; Angela Dispenzieri; Suzanne Hayman; David Dingli; Wilson Gonsalves; Joselle Cook; Saurabh Zanwar; Moritz Binder; Yi Lin; Taxiarchis Kourelis; Morie A. Gertz; Rahma Warsame; S. Vincent Rajkumar; Jad Sfeir; Nathan K. LeBrasseur; Shaji K. Kumar; Megan M. Weivoda
delete分享
delete收藏
Nivolumab consolidation in patients with double and triple hit high-grade B-cell lymphoma in complete metabolic remission after DA-EPOCH-RNivolumab巩固治疗在完成DA-EPOCH-R方案后达到完全代谢缓解的双打击和三打击高危B细胞淋巴瘤患者中的应用
delete2026-10-30
delete0
deleteOAAI
deleteA. Vera de Jonge; Erik van Werkhoven; Marjolein van der Poel; Koen de Heer; Clara P. W. Klerk; Yorick Sandberg; Rozemarijn van Rijn; Rob Fijnheer; Pim Mutsaers; Vibeke K. J. Vergote; Djamila Issa; Aart Beeker; Yavuz M. Bilgin; Lara H. Bohmer; Laurens Nieuwenhuizen; Wendy B. C. Stevens; Roel van Kampen; Rogier Mous; Marc Durian; Tjeerd Snijders; Joost S. P. Vermaat; Otto Visser; Josée M. Zijlstra; Anne I. J. Arens; Ben Zwezerijnen; Danielle van Assema; Bart de Keizer; Henk Hofwegen; Helma Zanders; Brigitta A. G. Schuthof; Robby E. Kibbelaar; Lianne Koens; Liping Fu; Daphne de Jong; David Kurtz; Marcel Nijland; Marie José Kersten; Martine E. D. Chamuleau
delete分享
delete收藏
Beyond binary: graded frailty assessment and outcomes after CAR-T cell therapy in relapsed/refractory multiple myeloma超越二元:分级衰弱评估及CAR-T细胞疗法在复发/难治性多发性骨髓瘤中的结局
delete2026-10-28
delete0
deleteOAAI
deleteH. Hashmi; Kevin Han; T. McCready; A. Tin; S. Rajeeve; G. Shah; H. Landau; M. Scordo; S. Giralt; A. Lesokhin; M. Merz; E. Jurgens; S. Mailankody; S. Z. Usmani; Armin Shahrokni
delete分享
delete收藏
Safety and efficacy of port use for CAR T-cell infusion in large B-cell lymphoma大型B细胞淋巴瘤中CAR T细胞输注使用港的安全性和有效性
delete2026-10-28
delete0
deleteOAAI
deleteZachary E. Hunzeker; Anath Lionel; Xiaowen Sun; Lei Feng; Sairah Ahmed; Amy Ayers; Michelly de Castro; Jaimole Varghese; Karla Ow; Taylor Cain; Minifrida Santiago; Sreekala Nair; Jeremy Ramdial; Elizabeth J. Shpall; Sattva S. Neelapu; Paolo Strati
delete分享
delete收藏
Outcomes with fractionated gemtuzumab ozogamicin in molecularly defined favorable-risk acute myeloid leukemia在分子学定义的预后良好风险急性髓系白血病中使用分次给予戈米舒单抗奥佐米星的疗效
delete2026-10-27
delete0
deleteOAAI
deleteNicholas Chornenki; Anita Liu; Yasser Abou Mourad; Reyna Altook; Hannah Cherniawsky; Shanee Chung; Donna Forrest; Deepesh Lad; Florian Kuchenbauer; Stephen H. Nantel; Sujaatha Narayanan; Thomas Nevill; Judith Rodrigo; Claudie Roy; Kevin Song; Cynthia Toze; Jennifer White; Eric Zhao; David Sanford; Ryan J. Stubbins
delete分享
delete收藏
Spatial profiling of extramedullary multiple myeloma demonstrates immune-excluded and suppressive tumor microenvironment髓外多发性骨髓瘤的空间分布特征显示其存在免疫排斥和抑制性的肿瘤微环境
delete2026-10-27
delete0
deleteOAAI
deleteMaximilian J. Steinhardt; Will Sherman; Mariam Stein; Yi Lin; Taxiarchis Kourelis; Dragan Jevremovic; Angela Dispenzieri; Morie A. Gertz; Karen L. Rech; Surendra Dasari; Jansen Seheult; Kevin Pavelko; Michael Strausbauch; Megan Weivoda; Wilson I. Gonsalves; Prashant Kapoor; S. Vincent Rajkumar; Shaji Kumar; Saurabh Zanwar
delete分享
delete收藏
Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial鲁索利替尼一线治疗与最佳可用疗法在真性红细胞增多症患者中的比较:随机RuxoBEAT试验结果
delete2026-10-22
delete0
deleteOAAI
deleteSteffen Koschmieder; Susanne Isfort; Lino L. Teichmann; Philippe Schafhausen; Florian H. Heidel; Carl Crodel; Andreas Hochhaus; Martin Griesshammer; Katja Sockel; Philipp J. Jost; Denise Walther; Konstanze Döhner; Joachim R. Göthert; Markus Radsak; Marinela Augustin; Heiko Becker; Aristoteles Giagounidis; Markus Schaich; Martine Klausmann; Nikolas von Bubnoff; Frank Stegelmann; Maike Kortmann; Michelle Zentis; Julia Frank; Anna Hagemeier; Martin Hellmich; Tim H. Brümmendorf
delete分享
delete收藏
Early treatment failure after ciltacabtagene autoleucel in multiple myeloma with high-risk features: implications for risk-informed care具有高危特征的多发性骨髓瘤在应用cilta-cabtagene autoleucel治疗后早期失败:对风险知情护理的启示
delete2026-10-22
delete0
deleteOAAI
deleteDoris K. Hansen; Saurabh Zanwar; Lauren C. Peres; Danai Dima; Omar Castaneda Puglianini; Alicia Richards; Mahmoud R. Gaballa; Oren Pasvolsky; Aimaz Afrough; Brett M. Reid; Ariel Grajales-Cruz; Zhuoer Xie; Utkarsh Goel; Aishwarya Sannareddy; Christen M. Dillard; Christopher J. Ferreri; Shebli Atrash; Cindy Varga; Andrew J. Portuguese; Hitomi Hosoya; Lekha Mikkilineni; Nilesh Kalariya; Damian Mikulski; Charlotte B. Wagner; Christopher R. Cahoon; Peter Cheng; Christian A. Gordillo; Eli Zolotov; Evguenia Ouchveridze; Jeries Kort; Raffaella Cassano Cassano; Shonali Midha; James A. Davis; Rebecca Gonzalez; Megan M. Herr; Hamza Hassan; Sneha Purvey; Marcus J. Geer; Kimberly Green; Laura B. Oswald; Fabiana Perna; Hien D. Liu; Taiga Nishihori; Jack Khouri; Shahzad Raza; Faiz Anwer; Susan Bal; Omar Nadeem; Ciara L. Freeman; Rahul Banerjee; Leyla Shune; Ran Reshef; Kenneth H. Shain; Melissa Alsina; Rachid C. Baz; Douglas W. Sborov; Peter Voorhees; Larry D. Anderson; Luciano J. Costa; Noa Biran; Shaji K. Kumar; Frederick L. Locke; Yi Lin; Surbhi Sidana; Krina K. Patel
delete分享
delete收藏
Immune reconstitution and clinical outcomes in B-ALL patients with versus without pre-HSCT Immunotherapy与未接受预HSCT免疫治疗相比,B-ALL患者中免疫重建与临床结局的关系
delete2026-10-21
delete0
deleteOAAI
deleteYu-Yuan Zeng; Guan-Hua Hu; Ying-Xi Zuo; Pan Suo; Lu Bai; Feng Zhang; Hui-Fang Wang; Ying-Jun Chang; Meng Lv; Xiao-Hui Zhang; Yu Wang; Lan-Ping Xu; Xiao-Jun Huang; Lin Wang; Yi-Fei Cheng
delete分享
delete收藏
Evaluation of gene expression assays to classify large B-cell lymphoma by molecular subtype using formalin-fixed paraffin-embedded tumor biopsies使用石蜡包埋肿瘤活检样本评估基因表达检测方法对大B细胞淋巴瘤进行分子亚型分类
delete2026-10-19
delete0
deleteOAAI
deleteNeha Akkad; Laura K. Hilton; Kumudha Balakrishnan; Dzifa Duose; Yasmine Yuen Man Lau; Aixiang Jiang; Subiksha Sankar; Okechukwu V. Nwogbo; Anindita Ghosh; Paul Young Erhumutemabor; Amy Ayers; Svetlana Paponova; Alexander Nesmelov; Pavel Zemskiy; Anastasiia Shvyrkova; Elizabeth Sheehan; Kelley Lauziere; Svetlana Podsvirova; Ekaterina Postovalova; Nikita Kotlov; Alexander Bagaev; Rajyalakshmi Luthra; L. Jeffrey Medeiros; Keyur P. Patel; Francisco Vega; Nathan Fowler; David W. Scott; Christopher R. Flowers
delete分享
delete收藏
Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myelomaDREAMM-3研究的最终分析结果:belantamab mafodotin与pomalidomide联合dexamethasone治疗复发/难治性多发性骨髓瘤的III期研究
delete2026-10-17
delete0
deleteOAAI
deleteMeletios Athanasios Dimopoulos; Vania Hungria; Haitao Meng; Atanas Radinoff; Jian Li; Sosana Delimpasi; Ting Niu; Gabor Mikala; Tamas Masszi; Marcelo Capra; Michael Low; Angelo Maiolino; Yan Xu; Xavier Leleu; Vasiliki Pappa; Dominik Chraniuk; Tatiana Konstantinova; Iurii Osipov; Shawn Hakim; Chris Brawley; Gabriela Tubel; Astrid McKeown; Julia Boyle; Sumita Roy-Ghanta; Katja Weisel
delete分享
delete收藏
An all-oral triplet regimen (decitabine/cedazuridine, venetoclax, and gilteritinib) for newly diagnosed and relapsed/refractory FLT3-mutated AML and high-risk MDS口服三联方案(地西他滨/西达苯胺、维奈克拉和吉列替尼)用于新诊断和复发/难治性FLT3突变急性髓系白血病及高风险骨髓增生异常综合征
delete2026-10-13
delete0
deleteOAAI
deleteRoberta S. Azevedo; Nicholas J. Short; Alex Bataller; Naval Daver; Tapan M. Kadia; Courtney DiNardo; Alexandre Bazinet; Ghayas Issa; Elias Jabbour; Gautam Borthakur; Jayastu Senapati; Wei-Ying Jen; Kelly Chien; Steven Kornblau; Dono Tippett; Musa Yilmaz; Guillermo Montalban-Bravo; Xuelin Huang; Wei Qiao; Hagop Kantarjian; Guillermo Garcia-Manero; Farhad Ravandi
delete分享
delete收藏
Subcutaneous isatuximab by on-body-injector plus bortezomib, lenalidomide, and dexamethasone in newly diagnosed transplant-ineligible multiple myeloma: ISASOCUT study皮下注射isasutuximab(通过自体注射器)联合硼替佐米、来那度胺和地塞米松治疗新诊断的移植不合格多发性骨髓瘤:ISASOCUT研究
delete2026-10-09
delete0
deleteOAAI
deleteArthur Bobin; Lisa Durocher; Cyrille Touzeau; Nicolas Branche; Aurore Perrot; Mamoun Dib; Jean-Sébastien Blade; Thomas Chalopin; Lydia Montes; Julie Gay; Mourad Tiab; Margaret Macro; Titouan Cazaubiel; Frédérique Orisini Piocelle; Alberto Santagostino; Adrienne De Thomas De Labarthe; Marlène Ochmann; Christophe Roul; Reza Tabrizi; Muriel Newinger-Porte; Olivier Fitoussi; Mony Morisse Chenda; Rick Zhang; Douaa Dhahri; Murielle Roussel; Lionel Karlin; Mohamad Mohty; Philippe Moreau; Anaïs Schavgoulidze; Jill Corre; Thierry Facon; Cyrille Hulin; Salomon Manier; Stéphanie Ragot; Xavier Leleu
delete分享
delete收藏
The GMALL B ALL/NHL 2002 protocol yields high rates of durable response in high grade B cell lymphomaGMALL B ALL/NHL 2002方案在高分级B细胞淋巴瘤中可实现高比例的持久缓解
delete2026-10-09
delete0
deleteOAAI
deleteSilvia Ferrari; Francesco Ballardini; Andrea Rossi; Anna Grassi; Chiara Pavoni; Monica Rondi; Paolo Fruscella; Andrea Gianatti; Giuseppe Gritti; Anna Maria Barbui; Federico Lussana; Alessandro Rambaldi
delete分享
delete收藏